Abstract
Angelman syndrome (AS) is a neurodevelopmental disorder characterised by severe mental retardation, absent speech, ataxia, sociable affect, and dysmorphic facial features. Eighty five percent of patients with AS have an identifiable genetic abnormality of chromosome 15q11-13. Mutations within the X linked MECP2 gene have been identified in patients with Rett syndrome (RTT), a neurodevelopmental disorder which affects females almost exclusively and which shares phenotypic overlap with AS. RTT is usually associated with normal development in infancy followed by loss of acquired skills and evolution of characteristic hand wringing movements and episodes of hyperventilation. A panel of 25 female and 22 male patients with a clinical diagnosis of AS and no molecular abnormality of 15q11-13 were screened for MECP2 mutations and these were identified in four females and one male. Following the diagnosis, it was possible to elicit a history of regression in three of these patients, who by then were showing features suggestive of Rett syndrome. In the remaining two subjects the clinical phenotype was still considered to be Angelman-like. These findings illustrate the phenotypic overlap between the two conditions and suggest that screening for MECP2 mutations should be considered in AS patients without a demonstrable molecular or cytogenetic abnormality of 15q11-13. Since MECP2 mutations almost always occur de novo, their identification will substantially affect genetic counselling for the families concerned. Keywords: Angelman syndrome; Rett syndrome; MECP2 mutations
Full Text
The Full Text of this article is available as a PDF (144.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boyd S. G., Harden A., Patton M. A. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr. 1988 Jun;147(5):508–513. doi: 10.1007/BF00441976. [DOI] [PubMed] [Google Scholar]
- Browne C. E., Dennis N. R., Maher E., Long F. L., Nicholson J. C., Sillibourne J., Barber J. C. Inherited interstitial duplications of proximal 15q: genotype-phenotype correlations. Am J Hum Genet. 1997 Dec;61(6):1342–1352. doi: 10.1086/301624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clayton-Smith J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet. 1993 Apr 1;46(1):12–15. doi: 10.1002/ajmg.1320460105. [DOI] [PubMed] [Google Scholar]
- Clayton-Smith J., Watson P., Ramsden S., Black G. C. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet. 2000 Sep 2;356(9232):830–832. doi: 10.1016/s0140-6736(00)02661-1. [DOI] [PubMed] [Google Scholar]
- Hagberg B. Clinical delineation of Rett syndrome variants. Neuropediatrics. 1995 Apr;26(2):62–62. doi: 10.1055/s-2007-979723. [DOI] [PubMed] [Google Scholar]
- Jiang Y., Lev-Lehman E., Bressler J., Tsai T. F., Beaudet A. L. Genetics of Angelman syndrome. Am J Hum Genet. 1999 Jul;65(1):1–6. doi: 10.1086/302473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997 Jan;15(1):70–73. doi: 10.1038/ng0197-70. [DOI] [PubMed] [Google Scholar]
- Laan L. A., Brouwer O. F., Begeer C. H., Zwinderman A. H., van Dijk J. G. The diagnostic value of the EEG in Angelman and Rett syndrome at a young age. Electroencephalogr Clin Neurophysiol. 1998 May;106(5):404–408. doi: 10.1016/s0013-4694(98)00007-8. [DOI] [PubMed] [Google Scholar]
- Laan L. A., Halley D. J., den Boer A. T., Hennekam R. C., Renier W. O., Brouwer O. F. Angelman syndrome without detectable chromosome 15q11-13 anomaly: clinical study of familial and isolated cases. Am J Med Genet. 1998 Mar 19;76(3):262–268. [PubMed] [Google Scholar]
- Nan X., Ng H. H., Johnson C. A., Laherty C. D., Turner B. M., Eisenman R. N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998 May 28;393(6683):386–389. doi: 10.1038/30764. [DOI] [PubMed] [Google Scholar]
- Scheffer I., Brett E. M., Wilson J., Baraitser M. Angelman's syndrome. J Med Genet. 1990 Apr;27(4):275–277. doi: 10.1136/jmg.27.4.275-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tate P., Skarnes W., Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet. 1996 Feb;12(2):205–208. doi: 10.1038/ng0296-205. [DOI] [PubMed] [Google Scholar]
- Wan M., Lee S. S., Zhang X., Houwink-Manville I., Song H. R., Amir R. E., Budden S., Naidu S., Pereira J. L., Lo I. F. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet. 1999 Dec;65(6):1520–1529. doi: 10.1086/302690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Webb T. Inv dup(15) supernumerary marker chromosomes. J Med Genet. 1994 Aug;31(8):585–594. doi: 10.1136/jmg.31.8.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams C. A., Angelman H., Clayton-Smith J., Driscoll D. J., Hendrickson J. E., Knoll J. H., Magenis R. E., Schinzel A., Wagstaff J., Whidden E. M. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet. 1995 Mar 27;56(2):237–238. doi: 10.1002/ajmg.1320560224. [DOI] [PubMed] [Google Scholar]
- Williams C. A., Zori R. T., Hendrickson J., Stalker H., Marum T., Whidden E., Driscoll D. J. Angelman syndrome. Curr Probl Pediatr. 1995 Aug;25(7):216–231. doi: 10.1016/s0045-9380(06)80036-8. [DOI] [PubMed] [Google Scholar]
- Xiang F., Buervenich S., Nicolao P., Bailey M. E., Zhang Z., Anvret M. Mutation screening in Rett syndrome patients. J Med Genet. 2000 Apr;37(4):250–255. doi: 10.1136/jmg.37.4.250. [DOI] [PMC free article] [PubMed] [Google Scholar]